Skip to content

TB still killing 4000 people with HIV each day, WHO reports

Hepatitis C still increasing in German gay men with HIV, reinfection common

Most patients in darunavir monotherapy trial stay fully suppressed

Mobile phone messages improve adherence and HIV control in Kenyan trial

Photo by Erik Hersman. Creative Commons via Flickr.

Protease inhibitor monotherapy in African setting results in viral load, but not CD4, failure in the short term

Persistent low-level viral load is associated with failure, but risk is small

Study confirms that the sooner treatment is started the better

One-pill regimen improves adherence and reduces hospitalisation in insured US patients

Taking HIV treatment and having an undetectable viral load associated with unprotected sex in Switzerland